Assessment of Risk Involved in the Combination Medicine of Paracetamol and Caffeine

Journal Title: Journal of Advances in Medical and Pharmaceutical Sciences - Year 2016, Vol 5, Issue 3

Abstract

Paracetamol (acetaminophen) with caffeine is a combination medicine indicated for the temporary relief of pain and discomfort associated with a number of conditions such as headache or muscle pain. There is a controversy going on this combination concerning their safety in patients, since 1 year later of their introduction in 1950. Paracetamol is a first-line therapy of choice in adults and children with fever and pain. Caffeine is used in this product to increase the pain relieving effects of paracetamol. Paracetamol has a narrow safety margin and there are number of risks associated with paracetamol. It is only safe and effective when used according to directions on OTC (Over-The-Counter) and Rx labeling. FDA (Food and Drug Administration) drug safety communication state that prescription paracetamol products to be limited to 325 mg per tablet, capsule, or other dosage unit, making these products safer for patients. Chronic or excessive administration of caffeine has been implicated in a range of dysfunctions involving the liver, renal system, gastrointestinal system, and musculature. It is difficult to arrive at standard dose, since caffeine is present in various consumer goods. The extent to which caffeine improves the analgesic effect of paracetamol is in doubt. Compared with paracetamol alone, a patient taking the combination of paracetamol with caffeine may be more likely to adverse effects than to get improved analgesia. The purpose of this study is to show the risk of liver damage, renal medullary necrosis and rebound headache associated with combination medicine of paracetamol and caffeine.

Authors and Affiliations

Md. Sahab Uddin, Md. Waliullah Wali, Abdullah Al Mamun, Md. Asaduzzaman, Md. Shah Amran, Mamunur Rashid

Keywords

Related Articles

Effect of Resveratrol on Some Biochemical Parameters in Lead-intoxicated Male Wistar Rats

Resveratrol is a potent antioxidant, demonstrated to ameliorate adverse effects of heat stress-induced toxicity. Information on the ameliorative effect of resveratrol on heavy metals induced organ toxicity is scanty. The...

Trypanostatic Effect of Millet-garlic Blended Diet on Rats Infected with T. b. brucei

Aim: The nutraceutic effect of millet-garlic blend against trypanosomiasis in Trypanosoma brucei brucei challenged rats was investigated in this study. Experimental Design: The experimental rats were grouped into A, B, C...

Effects of Various Concentrations of Quail Egg Solution on Glycemia and Antioxidant Parameters of Alloxan-induced Diabetic Rats

This study evaluated the effects of different concentrations of quail egg solution on glycemia and some antioxidant markers in alloxan-induced diabetic rats. Thirty adult male albino rats were assigned to 5 groups of 6 r...

Comparative Study on Efficacy of Intrathecal Injection Midazolam (2 mg) Versus Injection Metoclopramide IV in Prevention or Reduction of Nausea and Vomiting in Women during Caesarean Delivery under Spinal Anaesthesia

Background: Nausea and vomiting after spinal anaesthesia in caesarean are frequent causing distress to the patient and surgeon. To diminish the incidence various pharmacological agents were used with their limitations. T...

Evaluation of CNS Depressant, Antidiarrheal and Antipyretic Activities of Ethanolic Leaf Extract of Calophyllum inophyllum L. on Swiss Albino Mice

Objective: The main objective of the present study was to evaluate the CNS depressant, antidiarrheal and antipyretic activities of ethanolic leaf extract of Calophyllum inophyllum L. Methods: In the present study CNS dep...

Download PDF file
  • EP ID EP328538
  • DOI 10.9734/JAMPS/2016/22198
  • Views 120
  • Downloads 0

How To Cite

Md. Sahab Uddin, Md. Waliullah Wali, Abdullah Al Mamun, Md. Asaduzzaman, Md. Shah Amran, Mamunur Rashid (2016). Assessment of Risk Involved in the Combination Medicine of Paracetamol and Caffeine. Journal of Advances in Medical and Pharmaceutical Sciences, 5(3), 1-8. https://europub.co.uk/articles/-A-328538